Table: RaQualia Pharma - 9-MTH group results

RaQualia Pharma

10/11/2017 06:15

Nov 10 (Reuters)-  
             RaQualia Pharma Inc  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended        Year to   
                Sep 30, 2017        Sep 30, 2016      Dec 31, 2017   
                   LATEST             YEAR-AGO           LATEST      
                   RESULTS             RESULTS          FORECAST     
  Sales            606 mln                                1.18       
  Operating     loss 554 mln                          loss 791 mln   
  Recurring     loss 487 mln                          loss 777 mln   
  Net           loss 463 mln                          loss 778 mln   
  EPS          loss 24.16 yen                        loss 40.07 yen  
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
   
  NOTE - RaQualia Pharma Inc.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T 
  ((Tokyo Headline News Desk +813 6441 1812))